Defective PGM1 does not isomerise G6P to G1P

Stable Identifier
R-HSA-5609939
Type
Reaction [transition]
Species
Homo sapiens
Compartment
cytosol
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Defective PGM1 does not isomerise G6P to G1P
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Cytosolic phosphoglucomutase (PGM) catalyses the reversible conversion of glucose 6-phosphate (G6P) to glucose 1-phosphate (G1P), both precursor intermediates in glucose metabolism and protein glycosylation processes. Defects in PGM1 can cause Congenital disorder of glycosylation 1t (CDG1t, now known as PGM1-CDG; MIM:614921), a broad spectrum disorder characterised by under-glycosylated serum glycoproteins (Timal et al. 2012, Tegtmeyer et al. 2014). CDGs result in a wide variety of clinical features such as defects in nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. Mutations that cause almost complete loss of PGM1 activity include T115A, N38Y, D62H, D263Y and R221Vfs*13 (Tegtmeyer et al. 2014).
Literature References
PubMed ID Title Journal Year
22492991 Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing

Paprocka, J, Thiel, C, Morava, E, Rodenburg, RJ, Hoischen, A, Timal, S, van Spronsen, FJ, Veltman, J, Wevers, RA, Jamroz, E, Adamowicz, M, Lefeber, DJ, Huijben, K, Eidhof, I, Sykut-Cegielska, J, Lehle, L, Körner, C, Van den Heuvel, L, Gilissen, C

Hum. Mol. Genet. 2012
24499211 Multiple phenotypes in phosphoglucomutase 1 deficiency

Tegtmeyer, LC, Debus, V, Seyyedi, S, Rymen, D, Ficicioglu, C, He, P, Matalon, R, Petit, F, Laforêt, P, Huijben, K, Callewaert, N, Witten, A, Socha, P, Stojkovic, T, De Meirleir, L, Podskarbi, T, Schrapers, E, Shin, YS, Fingerhut, R, Aumaître, O, van Scherpenzeel, M, Timal, S, Vajro, P, Reunert, J, Lammens, M, DeClue, T, Vanderschaeghe, D, Losfeld, ME, Wada, Y, Czarnowska, E, Raymond, K, Ichikawa, M, van Spronsen, F, Sharma, V, Piraud, M, Marquardt, T, Rust, S, Veltman, J, Wevers, RA, Van Schaftingen, E, Jaeken, J, Matthijs, G, Sykut-Cegielska, J, Lefeber, DJ, Adamowicz, M, Stanley, CA, Ng, BG, Freeze, HH, Burda, P, Morava, E

N. Engl. J. Med. 2014
Participants
Input
Participates
as an event of
Catalyst Activity

phosphoglucomutase activity of PGM1 mutants:Mg2+ [cytosol]

Physical Entity
PGM1 mutants:Mg2+ [cytosol] (Homo sapiens)
Activity
phosphoglucomutase activity (GO:0004614)
Normal reaction
PGM1:Mg2+ isomerises G6P to G1P (Homo sapiens)
Functional status

Loss of function of PGM1 mutants:Mg2+ [cytosol]

Normal Entity
Disease Entity
Status
Disease
Name Identifier Synonyms
congenital disorder of glycosylation DOID:5212 carbohydrate-deficient glycoprotein syndrome
Authored
Jassal, B  (2014-07-18)
Reviewed
Spillmann, D  (2015-04-30)
Created
Jassal, B  (2014-07-18)
Cite Us!